Global Myelodysplastic Syndrome Drugs Market Size, Share and Report Analysis By Product (Hypomethylating Agents, Immunomodulatory Drugs, Targeted & Novel Therapies, Growth Factors & Supportive Agents, Cytotoxic Chemotherapy, Others), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035